Oral gepants: Revolutionizing migraine management in primary care
15 Nov 2025
byProf. Lawrence Wong, Emeritus Professor, Department of Medicine and Therapeutics, Chinese University of Hong Kong
Migraine is a common and debilitating neurological disorder that significantly impacts daily functioning and quality of life (QoL). Despite its high prevalence, migraine remains underdiagnosed and undertreated, particularly in the primary care setting. In an interview with MIMS Doctor, Professor Lawrence Wong, Emeritus Professor of the Department of Medicine and Therapeutics, Chinese University of Hong Kong, highlighted the importance of early diagnosis and timely intervention in migraine management. He noted that calcitonin gene-related peptide (CGRP)–targeted therapies, specifically oral gepants, offer a convenient and effective option for primary care providers (PCPs) to prevent migraine attacks and reduce the long-term burden of the condition.
